Table 2.
UniProt Accession | Gene Name | Protein (Sorted by Decreasing Protein Ratio) |
Protein Ratio Met/NoMet |
Adjusted p-Value | Frequency | |
---|---|---|---|---|---|---|
Metastasizing pUM | Non-Metastasizing pUM | |||||
DE Proteins Most Abundant in Metastasizing pUM | ||||||
P23381 | WARS1 | Tryptophan--tRNA ligase, cytoplasmic | 1.906 | 4.6 × 10−6 | 53 | 47 |
P04439 | HLA-A | HLA class I histocompatibility antigen, A alpha chain | 1.818 | 1.6 × 10−6 | 53 | 47 |
P61769 | B2M | Beta-2-microglobulin | 1.768 | 2.7 × 10−5 | 47 | 39 |
P01903 | HLA-DRA | HLA class II histocompatibility antigen, DR alpha chain | 1.727 | 9.2 × 10−5 | 53 | 47 |
Q03518 | TAP1 | Antigen peptide transporter 1 | 1.630 | 3.2 × 10−5 | 53 | 47 |
P10321 | HLA-C | HLA class I histocompatibility antigen, C alpha chain | 1.624 | 1.8 × 10−5 | 52 | 46 |
Q8IVF2 | AHNAK2 | Protein AHNAK2 | 1.616 | 8.8 × 10−4 | 44 | 36 |
O95816 | BAG2 | BAG family molecular chaperone regulator 2 | 1.595 | 2.3 × 10−7 | 42 | 39 |
P07686 | HEXB | Beta-hexosaminidase subunit beta | 1.589 | 1.9 × 10−4 | 53 | 47 |
P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 1.562 | 1.4 × 10−5 | 53 | 47 |
P17931 | LGALS3 | Galectin-3 | 1.549 | 4.6 × 10−5 | 52 | 47 |
P19971 | TYMP | Thymidine phosphorylase | 1.534 | 9.4 × 10−4 | 53 | 47 |
P51810 | GPR143 | G-protein coupled receptor 143 | 1.530 | 4.6 × 10−4 | 53 | 47 |
Q06210 | GFPT1 | Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 | 1.505 | 3.8 × 10−5 | 53 | 47 |
Q9H3G5 | CPVL | Probable serine carboxypeptidase CPVL | 1.486 | 7.4 × 10−4 | 53 | 47 |
DE Proteins Least Abundant in Metastasizing pUM | ||||||
P04792 | HSPB1 | Heat shock protein beta-1 | 0.726 | 1.4 × 10−5 | 53 | 47 |
Q9UBI6 | GNG12 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 | 0.722 | 1.6 × 10−3 | 45 | 40 |
Q9BZQ8 | NIBAN1 | Protein Niban 1 | 0.720 | 1.2 × 10−3 | 53 | 47 |
Q8NC51 | SERBP1 | Plasminogen activator inhibitor 1 RNA-binding protein | 0.718 | 1.6 × 10−2 | 53 | 47 |
P28161 | GSTM2 | Glutathione S-transferase Mu 2 | 0.710 | 5.4 × 10−4 | 53 | 47 |
Q9P0M6 | MACROH2A2 | Core histone macro-H2A.2 | 0.708 | 1.1 × 10−5 | 47 | 39 |
Q9NUJ1 | ABHD10 | Mycophenolic acid acyl-glucuronide esterase, mitochondrial | 0.707 | 6.8 × 10−7 | 53 | 47 |
Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.697 | 2.3 × 10−7 | 53 | 47 |
P05387 | RPLP2 | 60S acidic ribosomal protein P2 | 0.697 | 4.1 × 10−5 | 53 | 47 |
P34913 | EPHX2 | Bifunctional epoxide hydrolase 2 | 0.688 | 8.4 × 10−5 | 53 | 47 |
Q02252 | ALDH6A1 | Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial | 0.681 | 1.3 × 10−6 | 53 | 47 |
P21266 | GSTM3 | Glutathione S-transferase Mu 3 | 0.676 | 2.6 × 10−3 | 53 | 47 |
P09211 | GSTP1 | Glutathione S-transferase P | 0.673 | 5.5 × 10−3 | 53 | 47 |
Q02338 | BDH1 | D-beta-hydroxybutyrate dehydrogenase, mitochondrial | 0.672 | 1.4 × 10−5 | 50 | 44 |
O75891 | ALDH1L1 | Cytosolic 10-formyltetrahydrofolate dehydrogenase | 0.604 | 4.6 × 10−6 | 46 | 42 |
The above proteins were selected from 402 total differentially expresssed (DE) proteins identified by LC MS/MS iTRAQ technology (see Supplementary Table S6). Note that the protein ratio is expressed as metastasizing pUM (Met)/non-metastasizing pUM (noMet); DE proteins least abundant in metastasizing pUM are most abundant in non-metastasizing pUM.